Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Thymectomy | Research

Investigating the effectiveness of intraoperative rapid parathyroid hormone assay in parathyroidectomy surgery in patients with secondary hyperparathyroidism

Authors: Shirzad Nasiri, Seyed Mostafa Meshkati Yazd, Alireza Heshmati, Abnoos Mokhtari Ardekani, Masoud Najafi, Reza Shahriarirad

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Introduction

The use of Rapid Intraoperative parathyroid hormone (Io-PTH) assay during surgery in the management of parathyroid tissue in cases of primary hyperparathyroidism has been proven to be effective, while its utilization in secondary hyperparathyroidism (SHPT) has been rarely reported. In the present study, we aim to demonstrate the application of rapid Io-PTH assay in patients with SHPT following chronic kidney disease undergoing parathyroidectomy surgery.

Method

In this prospective study, five blood samples were taken from patients undergoing parathyroidectomy and upper thymectomy. Among the samples, two were pre-excision, including prior to the first incision, after exploration, and before parathyroids resection. Two additional samples were taken 10 and 20 min after the excision of the parathyroid glands. Another sample was collected twenty-four hours after the operation. Serum Calcium levels and PTH levels were evaluated and analyzed.

Results

We successfully managed SHPT in all 36 patients in our study. The patients included 24 males (66.7%) with a mean age of 49.97 ± 14.92. The mean PTH decreased significantly at 10 min, 20 min, one day, and six months after surgery (P < 0.001). The highest reduction occurred 10 min after removal of the parathyroid glands so the mean PTH compared to time zero was reduced from 1737 to 439, and in 100% of cases, more than 50% reduction was seen in PTH.

Conclusion

A 60% or more reduction in PTH Rapid at 10 min after parathyroidectomy has an accuracy of 94.4% and a positive predictive value of 100%. Thus, if the PTH level does not decrease by more than 60% at 10 min or more than 80% at 20 min, tissue exploration is continued with the aim of finding the ectopic parathyroid gland.
Literature
1.
go back to reference Llach F, Velasquez Forero F. Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects. Am J Kidney Dis. 2001;38(5 Suppl 5):S20-33.CrossRefPubMed Llach F, Velasquez Forero F. Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects. Am J Kidney Dis. 2001;38(5 Suppl 5):S20-33.CrossRefPubMed
2.
go back to reference Ivarsson KM, Akaberi S, Isaksson E, Reihner E, Rylance R, Prutz KG, Clyne N, Almquist M. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant. 2015;30(12):2027–33.CrossRefPubMedPubMedCentral Ivarsson KM, Akaberi S, Isaksson E, Reihner E, Rylance R, Prutz KG, Clyne N, Almquist M. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant. 2015;30(12):2027–33.CrossRefPubMedPubMedCentral
3.
go back to reference Isaksson E, Sterner G. Early development of secondary hyperparathyroidism following renal transplantation. Nephron Clin Pract. 2012;121(1–2):c68-72.CrossRefPubMed Isaksson E, Sterner G. Early development of secondary hyperparathyroidism following renal transplantation. Nephron Clin Pract. 2012;121(1–2):c68-72.CrossRefPubMed
4.
go back to reference Rodriguez-Ortiz ME, Rodriguez M. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Res. 2020;9:F1000.CrossRefPubMedPubMedCentral Rodriguez-Ortiz ME, Rodriguez M. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Res. 2020;9:F1000.CrossRefPubMedPubMedCentral
6.
go back to reference Pattou FN, Pellissier LC, Noel C, Wambergue F, Huglo DG, Proye CA. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg. 2000;24(11):1330–4.CrossRefPubMed Pattou FN, Pellissier LC, Noel C, Wambergue F, Huglo DG, Proye CA. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg. 2000;24(11):1330–4.CrossRefPubMed
7.
go back to reference Hiramitsu T, Tomosugi T, Okada M, Futamura K, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T. Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism. J Int Med Res. 2021;49(3):03000605211000987.CrossRefPubMedPubMedCentral Hiramitsu T, Tomosugi T, Okada M, Futamura K, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T. Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism. J Int Med Res. 2021;49(3):03000605211000987.CrossRefPubMedPubMedCentral
8.
go back to reference Chávez KV, Márquez-González H, Chavez-Tostado M. The Usefulness of Intraoperative PTH as a Predictor for Successful Parathyroidectomy in Secondary Hyperparathyroidism. Front Surg. 2021;8:232.CrossRef Chávez KV, Márquez-González H, Chavez-Tostado M. The Usefulness of Intraoperative PTH as a Predictor for Successful Parathyroidectomy in Secondary Hyperparathyroidism. Front Surg. 2021;8:232.CrossRef
9.
go back to reference Roche AM, Brant JA, Chai RL. Predictors of Readmission and Reoperation in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism. Otolaryngol Head Neck Surg. 2018;158(5):828–34.CrossRefPubMed Roche AM, Brant JA, Chai RL. Predictors of Readmission and Reoperation in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism. Otolaryngol Head Neck Surg. 2018;158(5):828–34.CrossRefPubMed
10.
go back to reference Oertli D, Udelsman R. Surgery of thyroid and parathyroid glands., 2nd edn. Berlin: Springer Science & Business Media; 2012. Oertli D, Udelsman R. Surgery of thyroid and parathyroid glands., 2nd edn. Berlin: Springer Science & Business Media; 2012.
11.
go back to reference Nasiri S, Meshkati Yazd SM, Kamran H, Kahrizi MS, Azhdari M, Shahriarirad R. Autotransplantation of parathyroid tissue into subcutaneous subclavicular area following total parathyroidectomy in secondary hyperparathyroidism. J Endocrinol Invest. 2022;45(12):2291–7.CrossRefPubMed Nasiri S, Meshkati Yazd SM, Kamran H, Kahrizi MS, Azhdari M, Shahriarirad R. Autotransplantation of parathyroid tissue into subcutaneous subclavicular area following total parathyroidectomy in secondary hyperparathyroidism. J Endocrinol Invest. 2022;45(12):2291–7.CrossRefPubMed
12.
go back to reference Shahriarirad R, Meshkati Yazd SM, Ardekani A, Mokhtari Ardekani A, Moradi N, Nasiri S. Calcitriol supplementation before parathyroidectomy and calcium level after surgery in parathyroid adenoma patients: a randomized controlled trial. J Endocrinol Invest. 2023;46(5):985-990. https://doi.org/10.1007/s40618-022-01963-8. Epub 2022 Dec 2. Shahriarirad R, Meshkati Yazd SM, Ardekani A, Mokhtari Ardekani A, Moradi N, Nasiri S. Calcitriol supplementation before parathyroidectomy and calcium level after surgery in parathyroid adenoma patients: a randomized controlled trial. J Endocrinol Invest. 2023;46(5):985-990. https://​doi.​org/​10.​1007/​s40618-022-01963-8. Epub 2022 Dec 2.
13.
go back to reference Graceffa G, Cipolla C, Calagna S, Contino S, Melfa G, Orlando G, Antonini R, Corigliano A, Proclama MP, Mazzola S, et al. Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism. Sci Rep. 2022;12(1):3333.CrossRefPubMedPubMedCentral Graceffa G, Cipolla C, Calagna S, Contino S, Melfa G, Orlando G, Antonini R, Corigliano A, Proclama MP, Mazzola S, et al. Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism. Sci Rep. 2022;12(1):3333.CrossRefPubMedPubMedCentral
14.
go back to reference Lang BH, Fung MMH. Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism. Surgery. 2021;169(1):109–13.CrossRefPubMed Lang BH, Fung MMH. Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism. Surgery. 2021;169(1):109–13.CrossRefPubMed
15.
go back to reference Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success?: a study of 352 consecutive patients. Arch Surg. 2006;141(5):483–8.CrossRefPubMed Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success?: a study of 352 consecutive patients. Arch Surg. 2006;141(5):483–8.CrossRefPubMed
16.
go back to reference Dotzenrath C, Goretzki PE, Roher HD. Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients. Langenbecks Arch Chir. 1996;381(1):46–50.PubMed Dotzenrath C, Goretzki PE, Roher HD. Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients. Langenbecks Arch Chir. 1996;381(1):46–50.PubMed
17.
go back to reference Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146(3):280–5.CrossRefPubMed Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146(3):280–5.CrossRefPubMed
18.
go back to reference Riss P, Asari R, Scheuba C, Niederle B. Current trends in surgery for renal hyperparathyroidism (RHPT)—an international survey. Langenbecks Arch Surg. 2013;398(1):121–30.CrossRefPubMed Riss P, Asari R, Scheuba C, Niederle B. Current trends in surgery for renal hyperparathyroidism (RHPT)—an international survey. Langenbecks Arch Surg. 2013;398(1):121–30.CrossRefPubMed
19.
go back to reference Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I. More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis. 2001;38(4):S168–71.CrossRefPubMed Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I. More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis. 2001;38(4):S168–71.CrossRefPubMed
20.
go back to reference Yamashita H, Gao P, Cantor T, Noguchi S, Uchino S, Watanabe S, Ogawa T, Kawamoto H, Fukagawa M. Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery. 2004;135(2):149–56.CrossRefPubMed Yamashita H, Gao P, Cantor T, Noguchi S, Uchino S, Watanabe S, Ogawa T, Kawamoto H, Fukagawa M. Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery. 2004;135(2):149–56.CrossRefPubMed
21.
go back to reference Di Stasio E, Carrozza C, Pio Lombardi C, Raffaelli M, Traini E, Bellantone R, Zuppi C. Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem. 2007;40(9–10):595–603.CrossRefPubMed Di Stasio E, Carrozza C, Pio Lombardi C, Raffaelli M, Traini E, Bellantone R, Zuppi C. Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem. 2007;40(9–10):595–603.CrossRefPubMed
22.
go back to reference Vulpio C, Bossola M, Di Stasio E, Pepe G, Nure E, Magalini S, Agnes S. Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. Clin Biochem. 2016;49(7–8):538–43.CrossRefPubMed Vulpio C, Bossola M, Di Stasio E, Pepe G, Nure E, Magalini S, Agnes S. Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. Clin Biochem. 2016;49(7–8):538–43.CrossRefPubMed
23.
go back to reference Chen J, Jia X, Kong X, Wang Z, Cui M, Xu D. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis. Nephrology. 2017;22(5):388–96.CrossRefPubMed Chen J, Jia X, Kong X, Wang Z, Cui M, Xu D. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis. Nephrology. 2017;22(5):388–96.CrossRefPubMed
24.
go back to reference Clark OH, Duh Q-Y, Kebebew E, Gosnell JE, Shen WT. Textbook of endocrine surgery: JP Medical Ltd. 2016. Clark OH, Duh Q-Y, Kebebew E, Gosnell JE, Shen WT. Textbook of endocrine surgery: JP Medical Ltd. 2016.
25.
go back to reference Dotzenrath C, Cupisti K, Goretzki P, Mondry A, Vossough A, Grabensee B, Röher H-D. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg. 2003;387:348–54.CrossRefPubMed Dotzenrath C, Cupisti K, Goretzki P, Mondry A, Vossough A, Grabensee B, Röher H-D. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg. 2003;387:348–54.CrossRefPubMed
26.
go back to reference Jimeno J, Pérez M, Pereira JA, Sancho JJ, Sitges-Serra A. Tratamiento quirúrgico del hiperparatiroidismo secundario recidivado. Cir Esp. 2005;78(1):34–8.CrossRefPubMed Jimeno J, Pérez M, Pereira JA, Sancho JJ, Sitges-Serra A. Tratamiento quirúrgico del hiperparatiroidismo secundario recidivado. Cir Esp. 2005;78(1):34–8.CrossRefPubMed
27.
go back to reference Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, Cichon S, Hubalewska-Dydejczyk A, Huszno B, Szybinski Z. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol. 2006;65(1):106–13.CrossRef Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, Cichon S, Hubalewska-Dydejczyk A, Huszno B, Szybinski Z. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol. 2006;65(1):106–13.CrossRef
28.
go back to reference Fei M, Xu D, Lai Y, Xu Y, Zhang J, Wang J. Comparison of Different Parathyroid Autograft Project after Total Parathyroidectomy in Patients with Secondary Hyperparathyroidism. In: Research Square Platform LLC. 2020. Fei M, Xu D, Lai Y, Xu Y, Zhang J, Wang J. Comparison of Different Parathyroid Autograft Project after Total Parathyroidectomy in Patients with Secondary Hyperparathyroidism. In: Research Square Platform LLC. 2020.
29.
go back to reference Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism—an evidence-based analysis. Langenbecks Arch Surg. 2009;394(5):765–84.CrossRefPubMed Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism—an evidence-based analysis. Langenbecks Arch Surg. 2009;394(5):765–84.CrossRefPubMed
30.
go back to reference Sitges-Serra A, Girvent M, Pereira JA, Jimeno J, Nogués X, Cano FJ, Sancho JJ. Bone Mineral Density in Menopausal Women with Primary Hyperparathyroidism before and after Parathyroidectomy. World J Surg. 2004;28(11):1148–52.CrossRefPubMed Sitges-Serra A, Girvent M, Pereira JA, Jimeno J, Nogués X, Cano FJ, Sancho JJ. Bone Mineral Density in Menopausal Women with Primary Hyperparathyroidism before and after Parathyroidectomy. World J Surg. 2004;28(11):1148–52.CrossRefPubMed
31.
go back to reference Solorzano CC, Carneiro-Pla DM, Irvin GL. Surgeon-Performed Ultrasonography as the Initial and Only Localizing Study in Sporadic Primary Hyperparathyroidism. J Am Coll Surg. 2006;202(1):18–24.CrossRefPubMed Solorzano CC, Carneiro-Pla DM, Irvin GL. Surgeon-Performed Ultrasonography as the Initial and Only Localizing Study in Sporadic Primary Hyperparathyroidism. J Am Coll Surg. 2006;202(1):18–24.CrossRefPubMed
32.
go back to reference Soon PSH, Delbridge LW, Sywak MS, Barraclough BM, Edhouse P, Sidhu SB. Surgeon Performed Ultrasound Facilitates Minimally Invasive Parathyroidectomy by the Focused Lateral Mini-incision Approach. World J Surg. 2008;32(5):766–71.CrossRefPubMed Soon PSH, Delbridge LW, Sywak MS, Barraclough BM, Edhouse P, Sidhu SB. Surgeon Performed Ultrasound Facilitates Minimally Invasive Parathyroidectomy by the Focused Lateral Mini-incision Approach. World J Surg. 2008;32(5):766–71.CrossRefPubMed
33.
go back to reference Torregrosa J-V, Fernández-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, Pons F, Rodriguez M. 99mTc-sestamibi Scintigraphy and Cell Cycle in Parathyroid Glands of Secondary Hyperparathyroidism. World J Surg. 2000;24(11):1386–90.CrossRefPubMed Torregrosa J-V, Fernández-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, Pons F, Rodriguez M. 99mTc-sestamibi Scintigraphy and Cell Cycle in Parathyroid Glands of Secondary Hyperparathyroidism. World J Surg. 2000;24(11):1386–90.CrossRefPubMed
34.
go back to reference Konturek A, Barczyński M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg. 2016;401(7):965–74.CrossRefPubMedPubMedCentral Konturek A, Barczyński M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg. 2016;401(7):965–74.CrossRefPubMedPubMedCentral
35.
go back to reference Kaczirek K, Riss P, Wunderer G, Prager G, Asari R, Scheuba C, Bieglmayer C, Niederle B. Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery. 2005;137(4):431–5.CrossRefPubMed Kaczirek K, Riss P, Wunderer G, Prager G, Asari R, Scheuba C, Bieglmayer C, Niederle B. Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery. 2005;137(4):431–5.CrossRefPubMed
36.
go back to reference Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery. 2004;136(6):1154–9.CrossRefPubMed Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery. 2004;136(6):1154–9.CrossRefPubMed
Metadata
Title
Investigating the effectiveness of intraoperative rapid parathyroid hormone assay in parathyroidectomy surgery in patients with secondary hyperparathyroidism
Authors
Shirzad Nasiri
Seyed Mostafa Meshkati Yazd
Alireza Heshmati
Abnoos Mokhtari Ardekani
Masoud Najafi
Reza Shahriarirad
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01378-3

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.